CustoMED

What CustoMED does

CustoMED (legally Customed Ltd.) is an Israeli healthtech company founded in 2023 as a spinout from Sheba Medical Center's 3D Printing & Innovation Lab, headquartered in Tel Aviv with 11-50 employees. The company operates CustoMED OS, an end-to-end AI-driven platform that converts raw medical imaging (CT and MRI scans) into patient-specific surgical plans, 3D-printable instruments, and custom implants for orthopedic procedures. Its core technical architecture combines computer vision for anatomical landmark extraction, generative AI for automated design file creation, and process automation that removes engineer dependencies from the scan-to-print workflow. The platform offers two delivery modes: AI Lab, a fully automated workflow where proprietary AI generates plans and designs with no engineer required, and Cloud Lab, an engineer-supported workflow with a shared cloud workspace for surgeon review and approval.

The product surface spans a wide range of patient-specific surgical outputs including joint cement spacers, surgical plans, cut and drill guides, anatomical models, patient-specific implants, intra-operative guidance, compression molds, and plate bending templates, organized into a Surgical Apps Suite covering orthopedic indications across Lower Extremity, Upper Extremity, Oncology, Pediatrics, Trauma, Joints, and CMF & Neuro, with additional indications listed as 'coming soon.' Customer segmentation is horizontal, addressing orthopedic surgeons, medical centers, implant manufacturers, and 3D printing labs, with value propositions tailored to each segment (surgical confidence for surgeons, scale and reduced turnaround for hospitals, personalization-as-a-service for implant OEMs, and throughput for 3D labs).

CustoMED's commercial model operates under undisclosed subscription and usage-based fees denominated in U.S. dollars, with a free 90-day evaluation license and a paid commercial license gated to users with a commercial agreement. Go-to-market is enterprise sales-led via a 'Book a Demo' motion and direct outreach. The company closed a $6 million seed round in October 2025 with a mix of institutional, strategic (including an unnamed leading orthopedic implant company), and government investors, and in April 2026 was selected for the inaugural cohort of ARC Landing Boston to support U.S. market entry. FDA and EU regulatory approvals are targeted for 2026, which would unlock commercial scale in the two largest Western medtech markets.

Name

CustoMED

Legal name

Customed Ltd.

Website

https://customed.ai

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

11–50 employees

Short description

CustoMED is an Israeli healthtech company providing an AI-driven platform that converts medical imaging into patient-specific surgical plans, 3D-printed instruments, and custom implants for orthopedic surgeons, medical centers, implant manufacturers, and 3D printing labs.

Ownership category

akta.pro rank

Product category

Orthopedic Surgical Planning Software

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113), Medical Equipment and Supplies Manufacturing (3391)

SIC

Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine) (HLAHAEAL)

akta.pro secondary industries

3D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial) (HLAHAEAJ), Medical Imaging AI (HDAAAEAH), Medical & Dental 3D Printing Services (patient-specific devices, dental labs) (IMAAADAG)

Keywords

• AI surgical planning
• Patient-specific implants
• 3D printing healthcare
• Orthopedic surgical software
• Personalized surgery platform

Headquarters

HQ city

Tel Aviv-yafo

HQ country

Israel

HQ region

Middle East

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain

Revenue model

1. Platform Subscription/Usage Fees: The use of the Services is subject to payment of particular fees as determined by the Company. Fees are charged in US Dollars and may be required in advance. The platform offers different service delivery methods: fully automatic by software, semi-automated through combination of software and manual efforts, or entirely through manual efforts by the Company's team.

Pricing tiers

Go-to-market motion2 records

Distribution channels1 record

Marketing channels2 records

Core offering

CustoMED provides an AI-powered software platform (CustoMED OS) that converts medical imaging scans into 3D surgical plans and patient-specific surgical instruments and implants. The platform offers two workflows — AI Lab (fully automated, no engineer required) and Cloud Lab (engineer-supported) — covering a full range of orthopedic indications and producing outputs such as cut & drill guides, anatomical models, patient-specific implants, joint cement spacers, intra-op guidance, compression molds, and plate bending templates.

Product overview

CustoMED is a single, end-to-end platform for personalized surgery. The core offering is CustoMED OS, which provides two workflows: AI Lab (fully automated) and Cloud Lab (engineer-supported). The platform converts medical scans into a full range of patient-specific surgical outputs including surgical plans, cut & drill guides, anatomical models, patient-specific implants, joint cement spacers, intra-op guidance, compression molds, and plate bending templates. A suite of surgical apps covers orthopedic indications across lower extremity (hip resurfacing, total knee replacement, high tibial osteotomy), upper extremity (distal radius/humerus ORIF, ulnar corrective osteotomy), oncology, trauma, and joints (shoulder arthroplasty, revision surgery). The technology is used in hundreds of surgeries worldwide.

Differentiator

Problem solved

Functional benefit

Products and services

• CustoMED OS An AI-powered, end-to-end operating system for personalized orthopedic surgery that converts medical imaging scans into 3D surgical plans, patient-specific surgical instruments, and implants. It offers two workflows: AI Lab (fully automated, no engineer required) and Cloud Lab (engineer-supported, real-time cloud collaboration). The platform serves orthopedic surgeons, hospitals and medical centers, implant manufacturers, and 3D printing labs across indications including Lower Extremity, Upper Extremity, Oncology, Pediatrics, Trauma, Joints, and CMF & Neuro.

Quantifiable outcome

• Hundreds of successful surgeries completed worldwide
• +1 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature5 records

Partnerships

Three partnerships are on record, tiered core and minor.

• ARC (Innovation arm of Sheba Medical Center)coreStrategic or Co-development Partner · 16 April 2026CustoMED is part of ARC Landing Boston inaugural cohort - a healthtech accelerator designed as a soft-landing platform for global healthtech companies entering the U.S. market. The initiative offers participants direct access to clinical environments, regulatory support, strategic mentorship, and integration into ARC's global investment platforms. The broader ARC portfolio exceeds $6.7B across 130+ startups.
• Massachusetts Governor Maura Healey AdministrationminorStrategic or Co-development Partner · 16 April 2026Partnership with Massachusetts Governor Maura Healey's administration for ARC Landing Boston accelerator initiative. Positioned as an economic driver for Massachusetts.
• Sheba Medical Center's 3D Printing & Innovation LabcoreStrategic or Co-development Partner · 30 October 2025CustoMED's technology originated from Sheba Medical Center's 3D Printing & Innovation Lab, suggesting ongoing research and development collaboration.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Brainlab: Brainlab provides surgical planning, navigation, and patient-specific instrumentation software across multiple surgical specialties including orthopedics and CMF. As a broad incumbent, it overlaps with CustoMED's intra-op guidance and planning modules.
• Stryker (Mako & Blueprint): Stryker offers the Mako robotic surgery platform and Blueprint patient-specific planning tools for orthopedics. As a broad incumbent, it competes with CustoMED across personalized joint replacement workflows while also leveraging a global sales force and implant installed base.
• Smith+Nephew (VISIONAIRE, CORI): Smith+Nephew provides VISIONAIRE patient-specific instrumentation and CORI surgical robotics. It is a broad orthopedic incumbent whose PSI and surgical-planning offerings directly overlap with CustoMED's automated guides and surgical plans.

Emerging players

• Insightec: Insightec uses AI and imaging-guided technology for incisionless procedures, illustrating how AI/imaging combinations are being commercialized in surgery. While not a direct orthopedic PSI peer, it represents the broader class of AI-driven image-to-treatment platforms relevant to CustoMED's trajectory.
• Medacta (MyKnee, MyShoulder): Medacta offers MyKnee, MyShoulder and other patient-specific instrumentation and planning products for orthopedics. It is comparable to CustoMED in personalized surgical solutions, though with broader implant system integration.

Direct peers

• Onkos Surgical: Onkos Surgical provides patient-specific implants and surgical solutions for musculoskeletal oncology and complex orthopedics. It competes with CustoMED in oncology and revision surgery indications.
• Renishaw (Neuro & Orthopedic 3D Printing): Renishaw manufactures patient-specific cranial and orthopedic implants using 3D printing technology. It is a direct peer in the patient-specific implant and instrumentation category that CustoMED targets.
• 3D Systems (Healthcare / VSP Orthopedics): 3D Systems' healthcare segment offers virtual surgical planning (VSP) and patient-specific anatomical models and guides. It is a direct peer to CustoMED's surgical planning and 3D-printed guide outputs.
• Conformis: Conformis specializes in patient-specific knee replacement implants and instrumentation, manufactured to match individual patient anatomy. Its product set mirrors CustoMED's personalized knee replacement and total knee arthroplasty app.
• Materialise: Materialise is the dominant independent provider of patient-specific surgical planning software and 3D-printed medical guides and implants. It overlaps directly with CustoMED's orthopedic PSI workflow across indications such as knee, hip, shoulder, and CMF.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/customed-ai

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds1 record

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CustoMED